PLOD1 and obesity disorder: Treatment with dapagliflozin for 32 weeks following an initial 32-week period of HFD feeding did not attenuate obesity or insulin resistance, however, it did enhance reproductive function, decrease adipocyte hypertrophy, and improve LH release.